LONDON & SAN DIEGO — Desktop Genetics Ltd (“DTG” or “the Company”), a software company revolutionizing the way biologists use CRISPR gene editing technology, announced today that it has received investment funding fromIllumina, Inc. (NASDAQ: ILMN), the global leader in next-generation sequencing (NGS) technology. The investment will be used to fund the continued development and […]
SAN FRANCISCO — Illumina, Inc. (NASDAQ:ILMN) announced today that Illumina Accelerator–the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry–has selected four new investments from a competitive pool of highly qualified applicants to be a part of its third funding cycle. “Illumina Accelerator is pleased to have such a […]
PRINCETON, NJ –– Certara®, the global biosimulation technology-enabled drug development company, today announced the release of version 15 of its Simcyp® Population-based Simulator. The Simcyp Simulator is the pharmaceutical industry’s most sophisticated physiologically-based pharmacokinetic (PBPK) modeling and simulation platform for determining first-in-human dose selection, predicting drug-drug interactions (DDIs), understanding drug disposition in special populations, including […]
FRANKFURT and NEW YORK — SAP SE (NYSE: SAP) announced SAP Foundation for Health and the SAP Medical Research Insights solution. Built on the SAP HANA platform, the new solutions reveal the value of patient data, from biomedical data to electronic medical records to clinical trials. They facilitate data integration and provide real-time analysis and […]
Wilmington, DE – The Pistoia Alliance HELM project has made two major announcements that help cement the reputation of HELM as the de-facto standard for describing and working with complex macromolecular structures. Firstly, HELM users can now take advantage of free MarvinBeans 5.0 licenses for the HELM toolkit. Secondly, RDKit is now HELM-enabled, making it […]
Cambridge, United Kingdom – At the annual meeting of the Metabolic Profiling Forum (MetaboMeeting 2015), Bruker today announced a new, integrated metabolomics solution, called MetaboScape®, which extends metabolomics data analysis for non-targeted experiments, based on metabolic pathway mapping. In the past decade, metabolomics has grown rapidly and has been widely adopted. The growing number of […]
SAN JOSE, Calif. – LifeMap Solutions, a digital-health subsidiary of BioTime, Inc. (NYSE MKT and TASE: BTX) known for its ResearchKit-enabled app Asthma Health, today announced that its HealthKit-compliant iOS app, COPD Navigator, is now available for free download from the App Store. Developed in close partnership with researchers from the Icahn School of Medicine […]
ST. LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced the PDX NGS Gateway Program, a service designed to enable partner personalized medicine initiatives. PierianDx CEO Ted Briscoe said the NGS Gateway Program was developed in direct response to feedback from customers based on the growth of personalized medicine efforts across the country. […]
LONDON, UK: Titian Software (www.titian.co.uk), has announced the appointments of James Craven, head of global marketing, and Angela Gray, Western US sales manager, to further consolidate its position as the world leader in sample management software. The successful launch earlier this year of Titian’s Mosaic Freezer Management, a cost-effective software package optimised for small to […]
PRINCETON, NJ –– Certara®, the global biosimulation technology-enabled drug development company, today announced that it has acquired XenologiQ, a UK-based quantitative systems pharmacology (QSP) consultancy. “This transaction strengthens Certara’s modeling and simulation capabilities, increases its leadership in mechanistic pharmacology, and supports the company’s precision medicine vision,” said Certara Chief Executive Officer Edmundo Muniz, M.D, Ph.D. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
